Background Arteriovenous malformations (AVMs) are vascular lesions that may be treated
by an endovascular approach using liquid embolic agents but the control of the liquid …

Endovascular embolization of brain arteriovenous malformations (AVMs) has improved with
liquid occlusive agents, but flow-related and anatomic restrictions limit endovascular …

Purpose We describe our experience using detachable tip microcatheters in the
embolization of brain arteriovenous malformations, pial arteriovenous fistulas and vein of …

The Outreach DAC is an intermediate-sized catheter designed for use with the Merci clot
retriever in acute stroke. We investigated its utility as an adjunctive device during AVM …

OBJECTIVE Liquid embolic agents have revolutionized endovascular management of
arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs). Nonetheless, since …

One of the procedural risks in arteriovenous malformation (AVM) embolization is possible
migration of the embolic agent into the venous drainage with an incomplete nidus occlusion …

During embolization of a large frontal arteriovenous malformation (AVM), Onyx-18 (eV3) was
injected into an M3 branch of the middle cerebral artery via a Marathon microcatheter (eV3) …

Liquid embolization of brain arteriovenous malformation using novel detachable tip micro
catheter: a technical report - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Background Brain arteriovenous malformations are vascular lesions that are increasingly
being treated with endovascular embolization. A potential complication with endovascular …

Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Aliso Viejo, CA, USA) and
Squid (Balt, Irvine, CA, USA) are 2 newer liquid embolic agents used in endovascular …